|
|
|
@ -58,6 +58,7 @@ She found that overall 8.4\% of all pipeline exits are due to strategic
|
|
|
|
terminations and that the rate of new drug production would be about 23\%
|
|
|
|
terminations and that the rate of new drug production would be about 23\%
|
|
|
|
higher if those strategic terminatations were elimintated
|
|
|
|
higher if those strategic terminatations were elimintated
|
|
|
|
(\cite{khmelnitskaya_competition_2021}).
|
|
|
|
(\cite{khmelnitskaya_competition_2021}).
|
|
|
|
|
|
|
|
% causal separation of strategic exits etc.
|
|
|
|
|
|
|
|
|
|
|
|
% Waring, Arrosmith, Leach, et al (2015)
|
|
|
|
% Waring, Arrosmith, Leach, et al (2015)
|
|
|
|
% - Atrition of drug candidates from four major pharma companies
|
|
|
|
% - Atrition of drug candidates from four major pharma companies
|
|
|
|
|